Placebo of BELAPECTIN clinical trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis.

This study is testing a new medicine called Belapectin. It's for people with liver scarring (cirrhosis) from NAFLD, to see if it can stop a serious problem called oesophageal varices from forming. Researchers want to know if it's safe and if it works better than a dummy medicine.